CLINICAL_TRIALS
ClinicalTrials.gov record update
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01106534
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:28.699812+00:00
- Published At
- 2016-06-28T00:00:00+00:00
- Record Updated At
- 2023-11-14
- Results Posted At
- 2016-06-28
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Chronic Total Occlusion of Coronary Artery", "Vascular Disease", "Myocardial Ischemia", "Coronary Artery Stenosis", "Coronary Disease", "Coronary Artery Disease", "Coronary Restenosis"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-11-14"- protocolSection.identificationModule.nctId
"NCT01106534"- protocolSection.identificationModule.officialTitle
"XIENCE V\u00ae Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V\u00ae USA DAPT Cohort) (XVU-AV DAPT)"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE4"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2016-06-28"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.